272 related articles for article (PubMed ID: 36466365)
21. 3D printed medicines: A new branch of digital healthcare.
Awad A; Trenfield SJ; Gaisford S; Basit AW
Int J Pharm; 2018 Sep; 548(1):586-596. PubMed ID: 30033380
[TBL] [Abstract][Full Text] [Related]
22. 3D-printed solid oral dosage forms for mental and neurological disorders: recent advances and future perspectives.
Wojtyłko M; Lamprou DA; Froelich A; Kuczko W; Wichniarek R; Osmałek T
Expert Opin Drug Deliv; 2023 Dec; ():1-19. PubMed ID: 38078427
[TBL] [Abstract][Full Text] [Related]
23. Stereolithography 3D printing technology in pharmaceuticals: a review.
Deshmane S; Kendre P; Mahajan H; Jain S
Drug Dev Ind Pharm; 2021 Sep; 47(9):1362-1372. PubMed ID: 34663145
[TBL] [Abstract][Full Text] [Related]
24. Additive Manufacturing and Printing Approaches for the Development of Pharmaceutical Dosage Forms with Improved Biopharmaceutical Attributes.
Kawish SM; Sharma S; Almalki WH; Alghamdi S; Afzal O; Kazmi I; Altamimi ASA; Al-Abbasi FA; Beg S; Ahmad FJ
Curr Drug Metab; 2022; 23(8):616-629. PubMed ID: 35713126
[TBL] [Abstract][Full Text] [Related]
25. Advancing non-destructive analysis of 3D printed medicines.
Jørgensen AK; Ong JJ; Parhizkar M; Goyanes A; Basit AW
Trends Pharmacol Sci; 2023 Jun; 44(6):379-393. PubMed ID: 37100732
[TBL] [Abstract][Full Text] [Related]
26. Pharmaceutical Product Development Exploiting 3D Printing Technology: Conventional to Novel Drug Delivery System.
Alam MS; Akhtar A; Ahsan I; Shafiq-Un-Nabi S
Curr Pharm Des; 2018; 24(42):5029-5038. PubMed ID: 30727872
[TBL] [Abstract][Full Text] [Related]
27. Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals.
Rautamo M; Kvarnström K; Sivén M; Airaksinen M; Lahdenne P; Sandler N
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32150899
[TBL] [Abstract][Full Text] [Related]
28. Recent update of 3D printing technology in pharmaceutical formulation development.
Gaurav ; Hasan N; Malik AK; Singh V; Raza K; Ahmad FJ; Kesharwani P; Jain GK
J Biomater Sci Polym Ed; 2021 Dec; 32(17):2306-2330. PubMed ID: 34387541
[TBL] [Abstract][Full Text] [Related]
29. Smartphone-enabled 3D printing of medicines.
Xu X; Seijo-Rabina A; Awad A; Rial C; Gaisford S; Basit AW; Goyanes A
Int J Pharm; 2021 Nov; 609():121199. PubMed ID: 34673166
[TBL] [Abstract][Full Text] [Related]
30. 3D Printing Pharmaceuticals: Drug Development to Frontline Care.
Trenfield SJ; Awad A; Goyanes A; Gaisford S; Basit AW
Trends Pharmacol Sci; 2018 May; 39(5):440-451. PubMed ID: 29534837
[TBL] [Abstract][Full Text] [Related]
31. 3D printing for oral drug delivery: a new tool to customize drug delivery.
Pandey M; Choudhury H; Fern JLC; Kee ATK; Kou J; Jing JLJ; Her HC; Yong HS; Ming HC; Bhattamisra SK; Gorain B
Drug Deliv Transl Res; 2020 Aug; 10(4):986-1001. PubMed ID: 32207070
[TBL] [Abstract][Full Text] [Related]
32. Trend of pharmaceuticals 3D printing in the Middle East and North Africa (MENA) region: An overview, regulatory perspective and future outlook.
Alzhrani RF; Alyahya MY; Algahtani MS; Fitaihi RA; Tawfik EA
Saudi Pharm J; 2024 Jun; 32(6):102098. PubMed ID: 38774811
[TBL] [Abstract][Full Text] [Related]
33. Three-Dimensional (3D)-Printed Zero-Order Released Platform: a Novel Method of Personalized Dosage Form Design and Manufacturing.
Fang D; Yang Y; Cui M; Pan H; Wang L; Li P; Wu W; Qiao S; Pan W
AAPS PharmSciTech; 2021 Jan; 22(1):37. PubMed ID: 33409925
[TBL] [Abstract][Full Text] [Related]
34. 3D printing of pharmaceuticals for disease treatment.
Chakka LRJ; Chede S
Front Med Technol; 2022; 4():1040052. PubMed ID: 36704231
[TBL] [Abstract][Full Text] [Related]
35. Disrupting 3D printing of medicines with machine learning.
Elbadawi M; McCoubrey LE; Gavins FKH; Ong JJ; Goyanes A; Gaisford S; Basit AW
Trends Pharmacol Sci; 2021 Sep; 42(9):745-757. PubMed ID: 34238624
[TBL] [Abstract][Full Text] [Related]
36. 3D printing in pharmaceuticals: An emerging technology full of challenges.
Wadher K; Trivedi R; Wankhede N; Kale M; Umekar M
Ann Pharm Fr; 2021 Mar; 79(2):107-118. PubMed ID: 32853575
[TBL] [Abstract][Full Text] [Related]
37. 3D Printing Technology in Pharmaceutical Dosage Forms: Advantages and Challenges.
Desu PK; Maddiboyina B; Vanitha K; Rao Gudhanti SNK; Anusha R; Jhawat V
Curr Drug Targets; 2021; 22(16):1901-1914. PubMed ID: 33494666
[TBL] [Abstract][Full Text] [Related]
38. Melt extrusion deposition (MED™) 3D printing technology - A paradigm shift in design and development of modified release drug products.
Zheng Y; Deng F; Wang B; Wu Y; Luo Q; Zuo X; Liu X; Cao L; Li M; Lu H; Cheng S; Li X
Int J Pharm; 2021 Jun; 602():120639. PubMed ID: 33901601
[TBL] [Abstract][Full Text] [Related]
39. Translating 3D printed pharmaceuticals: From hype to real-world clinical applications.
Seoane-Viaño I; Trenfield SJ; Basit AW; Goyanes A
Adv Drug Deliv Rev; 2021 Jul; 174():553-575. PubMed ID: 33965461
[TBL] [Abstract][Full Text] [Related]
40. Immediate release 3D printed oral dosage forms: How different polymers have been explored to reach suitable drug release behaviour.
Funk NL; Fantaus S; Beck RCR
Int J Pharm; 2022 Sep; 625():122066. PubMed ID: 35926751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
